meRfi®-GM

Biomarker

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Impact of biomarkers and primary tumor location on the metastatic CRC 1st-line treatment landscape in five European countries
Kafatos et al. 2021a
Metastatic lymph node ratio as a better prognostic tool than the TNM system in CRC
Macedo et al. 2021 Future Oncology 17: 1519–1532
microRNAs as biomarkers of ovarian cancer
Zhang & Lu 2020 Exp Rev Anticancer Ther 20: 373-385
Review
Rate of cancer progression as a predictive marker of efficacy of immunotherapy; an analysis in metastatic non-small-cell lung cancer
Prasanna et al. 2019 Immunotherapy - Future Medicine 11: 657–665
TMSB10 acts as a biomarker and promotes progression of clear cell RCC
Pan et al. 2020a Int. J. of Oncology 56: 1101-1114
Triple-negative breast cancer: promising prognostic biomarkers currently in development
Sukumar et al. 2021
Review
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence
Klempner et al. 2020
Review